Holen Sie sich die Stockscreener-App
140.07
0.33%
-0.46
Schlusskurs vom Vortag:
$140.53
Offen:
$141.18
24-Stunden-Volumen:
1.83M
Relative Volume:
1.41
Marktkapitalisierung:
$4.07B
Einnahmen:
$861.31M
Nettoeinkommen (Verlust:
$53.12M
KGV:
81.14
EPS:
1.7262
Netto-Cashflow:
$85.01M
1W Leistung:
+3.95%
1M Leistung:
+62.74%
6M Leistung:
+2.44%
1J Leistung:
-26.05%
1-Tages-Spanne:
$138.60
$147.03
1-Wochen-Bereich:
$132.39
$147.03
52-Wochen-Spanne:
$70.77
$216.01
Inspire Medical Systems Inc Stock (INSP) Company Profile
Firmenname
Inspire Medical Systems Inc
Sektor
Branche
Telefon
763-957-5037
Adresse
5500 WAYZATA BLVD, GOLDEN VALLEY
Vergleichen Sie INSP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INSP
Inspire Medical Systems Inc
|
140.07 | 4.08B | 861.31M | 53.12M | 85.01M | 1.7262 |
|
ABT
Abbott Laboratories
|
122.55 | 210.84B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.70 | 137.17B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
353.80 | 133.55B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.77 | 127.71B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.92 | 48.33B | 5.88B | 1.34B | 799.60M | 2.3489 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-12-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-11-26 | Hochstufung | Truist | Hold → Buy |
| 2025-11-25 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-11-24 | Hochstufung | Stifel | Hold → Buy |
| 2025-11-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-24 | Herabstufung | Jefferies | Buy → Hold |
| 2025-09-22 | Herabstufung | UBS | Buy → Neutral |
| 2025-09-02 | Eingeleitet | Evercore ISI | Outperform |
| 2025-08-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-08-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-08-05 | Herabstufung | Truist | Buy → Hold |
| 2024-11-20 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-05-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-04-19 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-03-19 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2024-01-19 | Eingeleitet | Jefferies | Buy |
| 2024-01-02 | Herabstufung | Stifel | Buy → Hold |
| 2023-12-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-04-14 | Eingeleitet | Mizuho | Buy |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-12-13 | Hochstufung | Goldman | Neutral → Buy |
| 2022-12-13 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2021-01-04 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-12-15 | Herabstufung | Goldman | Buy → Neutral |
| 2020-11-03 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-11-03 | Hochstufung | Oppenheimer | Underperform → Perform |
| 2020-09-22 | Eingeleitet | JP Morgan | Overweight |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-08-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-07-15 | Eingeleitet | Goldman | Buy |
| 2020-06-18 | Bestätigt | Piper Sandler | Overweight |
| 2020-05-18 | Eingeleitet | Lake Street | Buy |
| 2020-04-28 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-04-09 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-28 | Eingeleitet | Oppenheimer | Underperform |
| 2020-01-27 | Eingeleitet | Oppenheimer | Underperform |
| 2019-11-06 | Hochstufung | Berenberg | Sell → Hold |
| 2019-02-05 | Eingeleitet | Dougherty & Company | Buy |
| 2018-11-28 | Eingeleitet | Berenberg | Sell |
| 2018-10-29 | Eingeleitet | Leerink Partners | Outperform |
| 2018-05-29 | Eingeleitet | Guggenheim | Buy |
| 2018-05-29 | Eingeleitet | Stifel | Buy |
| 2018-05-29 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Inspire Medical Systems Inc Aktie (INSP) Neueste Nachrichten
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
INSP INVESTOR ALERT: $42.04 Stock Drop at Inspire Medical - GlobeNewswire
INSP INVESTOR ALERT: $42.04 Stock Drop at Inspire Medical Systems (INSP) Triggers Securities Fraud Lawsuit Over Concealed Medicare Billing Software Failures & Inspire V Inventory Glut - GlobeNewswire Inc.
Why Inspire Medical Systems (INSP) Stock Is Up Today - TradingView
Stocks of Inspire Medical Systems Inc (INSP) are poised to climb above their peers - Setenews
Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inspire Medical Systems - marketscreener.com
INSP SHAREHOLDER NEWS: Did Inspire Medical Systems, Inc. Mislead Investors? Contact BFA Law About The Ongoing Securities Class Action by January 5 Deadline - ACCESS Newswire
Inspire Medical Systems (INSP) Stock on December 9, 2025: Rebound Rally Meets Legal Overhang and Mixed Analyst Targets - ts2.tech
Inspire Medical Systems, Inc. (INSP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - GuruFocus
Inspire Medical (INSP) Crashes Over 32%, "Inspire V" Launch Failure, Hagens Berman Urges Investors with Losses to Contact Firm by Jan. 5 - PR Newswire
Dragoneer Investment Group LLC Grows Holdings in Inspire Medical Systems, Inc. $INSP - MarketBeat
Oppenheimer Upgrades Inspire Medical Systems (INSP) - Nasdaq
Shareholders who lost money in shares of Inspire Medical Systems, Inc. (NYSE: INSP) Should Contact Wolf Haldenstein Immediately - Eastern Progress
Piper Sandler raises Inspire Medical Systems stock price target to $165 on reimbursement news - Investing.com Canada
INSP Stockholders With Large Losses Can Lead the Inspire - GlobeNewswire
Inspire Medical Systems (INSP) Stock Trades Up, Here Is Why - Finviz
INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit ... - Bakersfield.com
INSP: Piper Sandler Maintains Overweight Rating and Increases Pr - GuruFocus
INSP Stock Gets Analyst Rating Upgrade to 'Outperform' | INSP St - GuruFocus
Investors who lost money on Inspire Medical Systems, Inc.(INSP) should contact The Gross Law Firm about pending Class ActionINSP - WV News
Oppenheimer Upgrades Inspire Medical Systems to Outperform From Market Perform, Price Target is $175 - marketscreener.com
Oppenheimer upgrades Inspire Medical stock to Outperform on pricing potential - Investing.com UK
Norges Bank Acquires New Shares in Inspire Medical Systems, Inc. $INSP - MarketBeat
INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
INSP DEADLINE: Faruqi & Faruqi Reminds Inspire Medical Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 5, 2026INSP - Newsfile
Head-To-Head Survey: Inspire Medical Systems (NYSE:INSP) versus iRhythm Technologies (NASDAQ:IRTC) - Defense World
2025-12-06 | Securities Lawsuit Alert: Inspire Medical Systems, Inc. (INSP) InvestorsContact Levi & Korsinsky Before January 5, 2026 | NYSE:INSP | Press Release - Stockhouse
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Inspire - GlobeNewswire
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Inspire Medical Systems, Inc. $INSP Shares Purchased by CW Advisors LLC - Defense World
American Century Companies Inc. Acquires 38,172 Shares of Inspire Medical Systems, Inc. $INSP - Defense World
Inspire Medical Systems (INSP) Price Target Increased by 12.39% to 128.11 - Nasdaq
INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit - cnhinews.com
INSP DEADLINE ALERT: Inspire Medical Systems, Inc. Securities Fraud Deadline is January 5Investors With Losses Urged to Contact BFA Law - ACCESS Newswire
Shareholders that lost money on Inspire Medical Systems, Inc.(INSP) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - PR Newswire
Shareholders SueWallSt in New Class Action Against Inspire Medical Systems, Inc.Act Now - Nasdaq
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inspire Medical Systems - marketscreener.com
Inspire Medical Systems (NYSE:INSP) Given New $180.00 Price Target at Robert W. Baird - Defense World
INSP Investors Have Opportunity to Lead Inspire Medical - GlobeNewswire
Robert W. Baird Increases Inspire Medical Systems (NYSE:INSP) Price Target to $180.00 - MarketBeat
Brown Capital Management LLC Has $47.68 Million Stake in Inspire Medical Systems, Inc. $INSP - MarketBeat
Inspire Medical Systems (INSP): Reassessing Valuation After a 65% One-Month Share Price Rebound - Yahoo Finance
Inspire Medical Systems, Inc. (NYSE:INSP) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Inspire Medical Systems, Inc. (NYSE:INSP) Receives Average Recommendation of “Hold” from Analysts - Defense World
Baird Maintains Inspire Medical Systems (INSP) Outperform Recommendation - Nasdaq
Inspire medical director sells $166k in INSP stock By Investing.com - Investing.com Australia
Investors SueWallSt Over Inspire Medical Systems, Inc. Stock DropContact Levi & Korsinsky to Join - ACCESS Newswire
Inspire medical director sells $166k in INSP stock - Investing.com
Levi & Korsinsky Reminds Inspire Medical Systems, Inc. - GlobeNewswire
INSP INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inspire Medical Systems - Markets Financial Content
Finanzdaten der Inspire Medical Systems Inc-Aktie (INSP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):